FXR ligands protect against hepatocellular inflammation via SOCS3 induction

Cellular Signalling
Zhizhen XuFengtian He

Abstract

Because of the anti-inflammatory actions of farnesoid X receptor (FXR) agonists, FXR has received much attention as a potential therapeutic target. However, the molecular mechanisms of actions have not yet been elucidated. In the present study, we reported that in the animal model of LPS-induced liver injury, administration of the FXR natural ligand CDCA could attenuate hepatocyte inflammatory damage, reduce transaminase activities, suppress inflammation mediators (IL-6, TNF-α and ICAM-1) expression and inhibit STAT3 phosphorylation. These protective effects of FXR were accompanied by an increased expression of suppressor of cytokine signaling 3 (SOCS3), which is a negative feedback regulator of cytokine-STAT3 signaling. We then demonstrated that the beneficial effects of FXR agonist in STAT3 activation were weakened by small interfering RNA-mediated SOCS3 knockdown in hepacytes. Moreover we observed both natural ligand CDCA and synthetic ligand GW4064 could upregulate SOCS 3 expression by enhancing the promoter activity in hepatocytes. These results suggest modulation of SOCS3 expression may represent a novel mechanism through which FXR activation could selectively affect cytokine bioactivity in inflammation response. FXR liga...Continue Reading

References

Sep 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y CalmusR Poupon
Feb 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·D J HiltonN A Nicola
Oct 24, 1998·The International Journal of Biochemistry & Cell Biology·R Starr, D J Hilton
May 21, 1999·Science·M MakishimaB Shan
Jul 7, 2000·The Journal of Biological Chemistry·A SasakiA Yoshimura
Aug 24, 2000·Journal of Medicinal Chemistry·P R MaloneyT M Willson
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·W XieR M Evans
Mar 30, 2001·The Journal of Biological Chemistry·S KamizonoA Yoshimura
Oct 20, 2004·The Journal of Biological Chemistry·Andrea BaetzAlexander H Dalpke
Jan 9, 2007·Molecular Immunology·Lynda A O'SullivanAlister C Ward
May 4, 2007·The Journal of Clinical Investigation·Wan-Wan Lin, Michael Karin
Nov 24, 2007·The International Journal of Biochemistry & Cell Biology·Ji Hoon YuHyeyoung Kim
Dec 7, 2007·Molecular and Cellular Neurosciences·Tizong MiaoPeter M Richardson
Oct 1, 2008·Cell Research·Yan-Dong WangWendong Huang
Oct 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yan-Dong WangWendong Huang
Jan 3, 2009·Biochemical and Biophysical Research Communications·Songwen ZhangDouglas C Harnish
May 6, 2009·Biochemical Pharmacology·Alexander H Sprague, Raouf A Khalil
Jul 18, 2009·Molecular Immunology·Yeddula NarayanaKithiganahalli Narayanaswamy Balaji
Nov 26, 2009·Toxicology and Applied Pharmacology·Katryn AllenBryan L Copple
Feb 1, 2011·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Barbara RengaStefano Fiorucci
Mar 8, 2011·Current Opinion in Infectious Diseases·Philipp J HohensinnerJohann Wojta
Jan 21, 2012·Biochemical Society Transactions·Gillian R MilneStephen J Yarwood

❮ Previous
Next ❯

Citations

Nov 28, 2012·Journal of Clinical Immunology·Gang HuangFengtian He
Jun 24, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chiara DegirolamoAntonio Moschetta
Jun 17, 2015·BioMed Research International·Chunlin JiangMing Kuang
Apr 2, 2013·Clinics in Liver Disease·Emina HalilbasicMichael Trauner
Dec 17, 2014·Cellular and Molecular Life Sciences : CMLS·Claire MazuyPhilippe Lefebvre
Oct 9, 2014·Frontiers in Aging Neuroscience·Stephen E AlwayJunaith S Mohamed
Jul 15, 2016·Liver International : Official Journal of the International Association for the Study of the Liver·Thomas HorvatitsValentin Fuhrmann
Oct 18, 2015·Biochemical and Biophysical Research Communications·Liangpeng LiYu Jiang
Oct 30, 2012·Journal of Chemical Information and Modeling·Weihua LiYun Tang
Oct 13, 2018·The Kaohsiung Journal of Medical Sciences·Chun-Zhong LinYu-Hai Hu
Oct 14, 2014·World Journal of Gastroenterology : WJG·Jiao-Ya XuGuang Ji
Jan 26, 2018·Digestive Diseases and Sciences·Gyorgy Baffy
Mar 7, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Claudia D FuchsMichael Trauner
Sep 30, 2015·Oncotarget·Fei GuoFengtian He
Jul 18, 2018·International Journal of Molecular Sciences·Chang Yeob Han
Dec 15, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Lei LiPeifeng Li
Aug 6, 2019·Frontiers in Endocrinology·Urša KovačTadeja Režen
Apr 26, 2021·Pharmacology & Therapeutics·Nana YanFrank J Gonzalez
Aug 3, 2021·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Philipp KönigshoferThomas Reiberger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Cell Adhesion Molecules in AS

Cell adhesion molecules expressed on the vascular endothelium and circulating leukocytes in response to inflammatory stimuli are implicated in atherosclerosis. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Related Papers

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
Zhizhen XuFengtian He
American Journal of Physiology. Gastrointestinal and Liver Physiology
Guodong LiGrace L Guo
© 2021 Meta ULC. All rights reserved